Rate Video

EHA 2015 | Molecular subtypes in diffuse large B-cell lymphoma

Christian Gisselbrecht • 12 Jun 2015

EHA 2015

Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease. At the 20th Congress of the European Hematology Association (EHA), Christian Gisselbrecht, MD, of Paris Diderot University, Paris, France, explains the clinical significance of molecularly subtyping DLBCL as germinal center B-cell (GCB) or non-GCB (activated B cell-like).

ASH 2014: Managing diffuse large B-cell lymphoma

Christian Gisselbrecht • 5 Dec 2014

CAR T-cells improve response and CR rates in R/R DLBCL

Christian Gisselbrecht • 14 Jun 2018

ZUMA-1 & SCHOLAR-1: comparison of outcomes in refractory DLBCL

Christian Gisselbrecht • 31 Aug 2020

Future directions for the treatment of diffuse large B-cell lymphoma

Christian Gisselbrecht • 12 Jun 2015

Related Videos

CAR T-cell therapy: the importance of LTFU

Integration of CAR T-cell therapy: working with industry

ZUMA-1 update: durable survival in R/R DLBCL patients treated with axi-cel

ZUMA-1 update: safety data of axi-cel in patients with R/R DLBCL